Lausanne, Switzerland

Karen Y Dane


 

Average Co-Inventor Count = 3.0

ph-index = 9

Forward Citations = 171(Granted Patents)


Location History:

  • Prilly, CH (2016 - 2017)
  • Lausanne, CH (2017 - 2019)
  • Auburn, AL (US) (2020 - 2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovative Contributions of Karen Y. Dane in Erythrocyte-Binding Therapeutics

Introduction

Karen Y. Dane, an inventive mind based in Lausanne, Switzerland, has made significant strides in the medical field with her groundbreaking work on erythrocyte-binding therapeutics. With a total of 14 patents to her name, her contributions continue to impact the realms of immunology and therapeutic research.

Latest Patents

Karen's recent patents encompass critical advancements in antigen-specific tolerance and compositions for its induction. Her work describes peptides that specifically bind to erythrocytes, provided as peptidic ligands or as antibodies and their fragments. These molecules can be engineered as molecular fusions with therapeutic agents, which can foster immunotolerance and target specific antigens. Notably, her innovations also include the application of targeting peptides that direct therapeutic fusions to specific sites, such as tumors, effectively recruiting erythrocytes to alter blood flow to these targets.

Career Highlights

Throughout her career, Karen has played a pivotal role in advancing biomedical research. Her association with esteemed institutions such as École Polytechnique Fédérale de Lausanne (EPFL) showcases her dedication to scientific inquiry and innovation. Colonel of a substantial number of patents, Karen's work not only contributes to academic knowledge but also holds the potential for real-world application in therapies aimed at a variety of diseases.

Collaborations

In her pursuit of innovation, Karen Y. Dane has collaborated with fellow researchers, including Stephan Kontos. These partnerships highlight the importance of teamwork in advancing scientific discoveries and bringing new ideas to fruition within the biomedical landscape.

Conclusion

Karen Y. Dane exemplifies the spirit of innovation that drives the medical field forward. With her significant contributions in erythrocyte-binding therapeutics and a robust patent portfolio, her work promises to pave the way for future advancements in immunology. As her research progresses, it is evident that her influence will resonate within the scientific community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…